BI
Swedish Orphan Biovitrum AB (publ)
BIOVF · OTC
$48.13 +0.00% (+$0.00)
1M -0.06%
Market Cap 160.3B kr
P/E Ratio 114.74x
Div. Yield -
ROE 3.58%
Bulios Fair Price
$57.68
19.9% upside
Trenutna cena
$48.13
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica BIOVF trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
6/9Valuation
41 /100
Fair P/E 114.74x
EV/EBITDA 13.88x
P/FCF 22.17x
Growth
64 /100
Stable EPS growth 45.32%
Rev. growth 14.45%
Book val. growth 12.36%
Profitability
87 /100
Strong Gross margin 51.63%
Net margin 4.57%
FCF margin 23.67%
Quality
42 /100
Average ROIC 14.05%
ROE 3.58%
Asset turnover 0.37x
Debt
73 /100
Low Debt/Equity 0.42x
Current ratio 0.88x
Net debt/EBITDA 1.30x
Stability
54 /100
Moderate Beta 0.29x
Rev. volatility 5.47%
Profitable years 6
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o BIOVF
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Guido Oelkers
Employees
1,888
Headquarters
Stockholm
Prihajajoči dogodki
27 OKT.
Earnings
Upcoming earnings report